Our services have evolved over time to meet the increasing need for health economic, evidence based solutions, clinical data management, regulatory and risk management; our vast experience across a wide range of disease areas is second to none.
We provide services at every stage of the product lifecycle including:
Pre-launch evaluations of disease burden and outcome evidence
Registration or global trial submission
Phase I-IV clinical trial management
Phase II/III patient reported outcomes and economic study design, conduct, analysis, and report
Development of comprehensive health economic models
Input into pricing decisions and develop strategy to meet market access requirements
Preparation of HTA and health outcomes value dossiers according to country requirement
Development of post-launch access strategy and communication tools
Develop regulatory and risk management strategic plan
